Newsletter

Australia: Comparison of Australian TGA Fees and Annual Charges for Medical Devices and IVDs (2025 vs. 2026) – June/July 2026

Australia: Comparison of Australian TGA Fees and Annual Charges for Medical Devices and IVDs (2025 vs. 2026) – June/July 2026

  • 2026-07-28 02:39:21

Starting July 2026, the Australian Therapeutic Goods Administration (TGA) will implement an overall increase in regulatory fees and annual charges for medical devices and in vitro diagnostic (IVD) devices. This article provides a detailed 2025 versus 2026 fee comparison, highlighting an upward adjustment of approximately 4.7% to 6.3% across various submission and maintenance categories. It also includes strategic insights from Qualtech on leveraging overseas approvals and managing hidden compliance costs to optimize long-term operational budgets and market access strategies

More
Philippines: Understanding FDA Administrative Order No. 2024-0016: Updated Fees and Guidelines for Medical Device Applications – February/March 2025

Philippines: Understanding FDA Administrative Order No. 2024-0016: Updated Fees and Guidelines for Medical Device Applications – February/March 2025

  • 2025-01-22 06:13:50

Administrative Order No. 2024-0016 sets a new schedule of fees and charges by the Food and Drug Administration (FDA) of the Philippines for all regulated products, including medical devices, drugs, food, and cosmetics. The updated fees aim to simplify compliance for manufacturers and distributors while keeping pace with the growing demands of the healthcare industry. This change ensures more efficient processes for licensing, product registration, and market access.

More